ACTEMRA – tocilizumab 200 mg/10 mL (20 mg/mL) and 400 mg/20 mL (20 mg/mL) intravenous solution

Westminster Pharmaceuticals

rheumatoid arthritis; polyarticular juvenile idiopathic arthritis; giant cell arteritis; adjunct tx for COVID-19 requiring oxygen or ventilation; systemic-onset juvenile idiopathic arthritis; cytokine release syndrome

giant cell arteritis; cytokine release syndrome; rheumatoid arthritis; adjunct tx for COVID-19 requiring oxygen or ventilation; systemic-onset juvenile idiopathic arthritis; polyarticular juvenile idiopathic arthritis

Fridge (2-8°C)